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Percutaneous Intra Arterial Thrombolysis on 
Peri-coronary Angiography Ischemic Stroke: Initial 
Experience in National Cardiac Center Harapan Kita
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Background. Ischemic stroke is a rare but well-known complication 
of cardiac-catheter interventions attributable mostly to embolism. Peri-
coronary angiography stroke, represents a unique opportunity for im-
mediate stroke interventional therapy with intravenous, catheter based 
intra-arterial thrombolysis (IAT) or combined therapy using recombinant 
tissue plasminogen activator (rtPA). Intra-arterial thrombolysis is an option 
for treatment of selected patients who have major stroke of < 6 hours 
duration due to occlusion of the Media Cerebral artery (MCA) and who are 
not otherwise candidates for intravenous rtPA (Class I, Level of Evidence 
B, AHA guidelines). 
Objective. To review the first experience of percutaneous intra-arterial 
thrombolysis (PIAT) as a management of acute ischemic stroke due to 
complication of coronary angiography procedure. 
Summary. We present 3 cases of acute ischemic stroke which happened 
during coronary angiography procedures. All of them (NIHSS 30, 20 and 
34) were treated immediately with intra-arterial thrombolysis (IAT) recom-
binant tissue Plasminogen Activator (rtPA) and had a very good outcome 
with no residual of stroke (NIHSS 0). Although it has been stated clearly 
in the AHA guidelines for the early management of adult with ischemic 
stroke, up until now the procedure of IAT or (intra-venous thrombolysis) 
IVT upon acute ischemic stroke is not established yet in standard operational 
procedure of National Cardiovascular Center Harapan Kita (NCCHK) 
Jakarta, which perhaps makes the physicians hesitate on performing these 
procedures due to legal aspects, while in the other hand the risks of acute 
ischemic stroke remain the potential threats on every single coronary 
angiography or any intensive catheter based procedures.
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Coronary angiography is associated with a peri-pro-
cedural stroke rate of 0.3%1. This risk is higher with 
interventional versus diagnostic coronary angiography. 
Peri-coronary angiography stroke may be related to air 
embolism, thrombus formation at the catheter tip, or 
thrombo-embolic material dislodged by the catheters 
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or from the aortic arc. Fluoroscopic time and severity 
of coronary artery disease (CAD) may increase the risk 
of peri-coronary angiography stroke.2 
Peri-coronary angiography stroke represents a 
unique opportunity for immediate stroke interven-
tional therapy with intra-venous, catheter based intra-
arterial thrombolysis (IAT) or combined therapy us-
ing recombinant tissue plasminogen activator (rtPA), 
prourokinase, or urokinase because of very short time 
to-treatment and readily available resources.3 Intra-
arterial thrombolysis is an option for treatment of 
selected patients who have major stroke of < 6 hours 
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duration due to occlusions of the MCA and who 
are not otherwise candidates for intravenous rtPA 
(Class I, Level of Evidence B). Treatment requires 
the patient to be at an experienced stroke center 
with immediate access to cerebral angiography and 
qualified interventionalists. Facilities are encouraged 
to define criteria to credential individuals who can 
perform intra-arterial thrombolysis (Class I, Level of 
Evidence C).8
In National Cardiac Center �arapan Kita (NC-
C�K) Jakarta Indonesia, last year we had 4 cases of 
acute ischemic stroke due to coronary angiography 
procedure, and this year we already have had 4 cases4 
and the last 3 cases were treated by intra-arterial throm-
bolysis with the good outcome results. Intra-arterial 
therapy is increasingly used in the treatment of acute 
stroke either as the primary modality for patients 
presenting 3 to 8 hours of symptoms onset or as an 
adjuvant measure in patients treated with intravenous 
tissue plasminogen activator (IV tPA) who do not im-
prove in a timely fashion. Primary IAT has been shown 
to be improved clinical outcome when administered 
3 to 6 hours from symptom onset using intra-arterial 
thrombolytics5 and is approved up to 8 hours using 
mechanical clot retrieval (Merci Retriever) or suction 
thrombectomy (Penumbra System). 6
According to SYNT�ESIS trial, rapid initiation 
of IAT is a safe and feasible alternative to IVT in acute 
ischemic stroke.7 A�A Guidelines 2007 for the early 
management of Adults with ischemic stroke stated 
that intravenous rtPA is recommended for selected 
patients who may be treated within 3 hours of onset 
of ischemic stroke (Class I, Level of Evidence A) and 
intra-arterial thrombolysis is an option for treatment 
of selected patients who have major stroke of < 6 hours 
duration due to occlusions of the Middle Cerebral 
Artery(MCA) and who are not otherwise candidates 
for intravenous rtPA (Class I, Level of Evidence B).8 
Furthermore, because recent advances in endovascular 
treatment techniques for stroke patients, nowadays it is 
possible to perform percutaneous transluminal angio-
plasty (PTA) of the intracranial artery as an adjuvant 
to intra-arterial thrombolysis.9
Case Illustration 1
Mr. DR, 74 years old came to National Cardiovascular 
Center �arapan Kita Jakarta (NCC�K) to have elec-
tive coronary angiography due to stable angina pectoris 
CCS II. �e was also diagnosed as post CABG 1996 
and 2004 with hypertension stage II. �e presented 
chest pain with moderate activity and diminish with 
rest or sublingual nitrate, with duration about 5-10 
minutes, the pain did not radiate and there were 
no diaphoretic, nausea nor vomiting. �e had been 
suffering these symptoms for last two months, with 
risk factors of hypertension and dyslipidemia. The 
treadmill test was performed with only 02 minutes 
11 second achieved. 
Physical examination revealed mild ill, blood pres-
sure was 150/80 mm�g, heart rate was 52 bpm, respi-
ratory rate 20 x/minutes, and body temperature was 
36,5o C. Auscultation revealed normal heart sound, 
normal vesicular sound with no rales and wheezing 
from lung examination, and other examinations was 
within normal limit.
The electrocardiogram showed sinus rhythm, QRS 
rate 50 bpm, QRS axis (-15), normal P wave, PR in-
terval 20 msec, QRS duration 6 msec, Q pathologic at 
III, aVF and slight T inverted at I, aVL, V5 and V6. 
The laboratory finding revealed hemoglobin was 12.6 
g/dl, �ematokrit 39 vol%, WBC 8620/ul, ureum 65 
mg/dl and creatinin level was 1.8 mg/dl. 
Chest X-ray revealed cardiac enlargement with 
cardio-thoracic ratio 55% with the prominent aortic 
segment and normal pulmonal segment, flattening 
of cardiac waist, downward apex and no conges-
tion nor infiltrate. Echocardiography showed EDD 
56mm, ESD 42mm, with the ejection fraction 48%, 
hypo-kinetic at posterior segment, normal valves and 
diastolic dysfunction with abnormal relaxation. �is 
last medications were ISDN 2 x 20 mg, bisoprolol 1 
x 2.5 mg, cardace 1 x 5 mg, amiodarone 1 x 200 mg, 
ascardia 1 x 80 mg, �CT 1 x 12.5 mg, simvastatin 1 
x 10 mg, micardis 1 x 80 mg. 
The coronary angiography was performed upon 
this patient with the result, LAD proximal stenosis 
95%, LCX proximal and RCA proximal, both were 
total occlusion, LRA-LAD graft was patent. The 
catheter was failed to advance to SVG-RCA and 
SVG-LCx grafts. After coronary angiography proce-
dure carried out, the patient felt fatique and unable 
to speak clearly. The right extremities were unable to 
move, the National Institute of �ealth Stroke Scale 
(NI�SS) was 30 (severe stroke). Then the patient 
was diagnosed as CAD 3 VD with graft failure at 
SVG-RCA and SVG-LCx with the complication 
of cerebrovascular disease stroke non hemorraghe 
(CVD SN�). 
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neurological deficit (mild stroke) and patient moved 
to adult ward on the next 3 days. Brain CT scan after 
24 hours of PIAT procedures showed no detection of 
intracranial hemorraghe. Now patient is stable at adult 
ward with NI�SS 0.
Case Illustration 2
Mr. MTZ, 72 years old came to National Cardiovas-
cular Center �arapan Kita Jakarta (NCC�K) ambu-
latory to have elective coronary angiography standby 
PTCA due to stable angina pectoris CCS II. �e was 
also diagnosed as post CABG 2001 with hypertension 
stage I and type 2 DM. �e presented chest pain with 
moderate activity and diminish with rest or sublingual 
nitrate, with duration about 5-10 minutes, the pain 
did not radiate and there were no diaphoretic, nausea 
nor vomiting. �e had been suffering these symptoms 
for one last month, with risk factors of hypertension, 
diabetes and dyslipidemia. Cardiac perfusion scanning 
was performed upon this patient and the result showed 
Patient was planned to perform cerebral percutane-
ous intra-arterial thrombolysis (PIAT) with r-TPA. MP 
Catheter was advanced to Left Internal Carotid Artery 
and cerebral angiography was carried out, showed total 
occlusion on Media Cerebral Artery (MCA). Then, the 
rTPA (actyles) was injected bolus  6 mg through the 
Microcatheter which placed upon MCA, angiography 
evaluation showed the occlusion begin to be opened, 
followed with actyles drip 0.9 mg/kgBW within an 
hour intra-catheter. Within 30 minutes rTPA drip, 
there was bleeding on the gum, angiography evaluation 
showed the occlusion was opened with good flow, the 
drip was stopped. Neurological examination showed 
patient was in good orientation, both extremities 
moved equally, the NI�SS was 3 (mild stroke) and 
moved to CVC unit. 
In CVC unit patient was fully alert, BP was 
208/88 mm�g, �R 51 bpm, with mild neurological 
deficit. BP was stable under intravenous perdipin 0.3 
mg/kgBW/minutes, MAP target was 100. Brain CT 
scan was performed with no detection of intracranial 
hemorraghe. Neurological expertise showed minimal 
Figure1. Case illustration 1: A. Before PIAT  B. After PIAT C. Brain CT showed ischemic stroke
A B C
Figure 2. Case illustration 2: A. Before PIAT B. After PIAT C. Brain CT showed ischemic stroke
A B C
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parsial defect at lateral wall as inducible ischemia.  
Physical examination revealed mild ill, blood pres-
sure was 134/70 mm�g, heart rate was 60 bpm, respi-
ratory rate 18 x/minutes, and body temperature was 
36,4o C. Auscultation revealed normal heart sound, 
normal vesicular sound with no rales and wheezing 
from lung examination, and other examinations was 
within normal limit.
The electrocardiogram showed sinus rhythm, QRS 
rate 50 bpm, QRS axis (-15), normal P wave, PR in-
terval 12 msec, QRS duration 4 msec, Q pathologic 
at III and aVF, slight T inverted at I and aVL. The 
laboratory finding revealed hemoglobin was 15.3 g/
dl, �ematokrit 45 vol%, WBC 12900/ul, ureum 43 
mg/dl and creatinin level was 0.9 mg/dl. 
Chest X-ray revealed cardiac enlargement with 
cardio-thoracic ratio 60% with the prominent aortic 
segment and normal pulmonal segment, flattening of 
cardiac waist, downward apex and no congestion nor 
infiltrate. Echocardiography showed EDD 41mm, 
ESD 27mm, with the ejection fraction 65%, hypo-
kinetic at posterior segment, normal valves and dia-
stolic dysfunction with abnormal relaxation. �is last 
medications were tanapress 1 x 10 mg, maintate 1 x 5 
mg, vascardin 3 x 10 mg, thromboaspilet 1 x 80 mg, 
glucophage 2 x 500 mg, alganax 1 x 0.25 mg. 
The coronary angiography was performed upon 
this patient with the result, LAD proximal stenosis 
90%, diffuse stenosis proximal-mid 70-90%. LCX 
subtotal occlusion at distal part and OM 2, OM1 
stenosis 80% at proximal-mid, RCA collateral to distal 
part LCx. RCA total occlusion at proximal with bridg-
ing collateral to distal part. Both SVG-D1 graft and 
SVG-PDA graft were patents, LIMA-LAD graft was 
total occlusion on distal incersion. The catheter was 
failed to advance to SVG-OM graft. After coronary 
angiography procedure carried out, the patient com-
plaint of tiredness and unable to speak clearly. The 
right extremities were unable to move and the com-
munication was inadequate, the National Institute of 
�ealth Stroke Scale (NI�SS) was 28 (severe stroke). 
MSCT brain was performed and showed ischemic 
stroke, no detection of intracranial hemorraghe. Then 
the patient was diagnosed as CAD 3 VD with graft 
failure at LIMA-LAD, SVG-OM with the complica-
tion of CVD SN�. 
Patient was planned to perform cerebral percutane-
ous intra-arterial thrombolysis (PIAT) with r-TPA. JR 
Catheter was advanced to Left Internal Carotid Artery 
and cerebral angiography was carried out, showed 
thrombus with stenosis Left Media Cerebral Artery 
(MCA). Then, the rTPA (actyles) was injected bolus 
5 mg through the Microcatheter which placed upon 
MCA, angiography evaluation showed the occlusion 
begin to be opened, followed with actyles drip 10 mg 
within 30 minutes intra-catheter. Angiography evalu-
ation showed thrombus was reduced. The rTPA drip 
was continued 10 mg within 30 minutes. Angiography 
evaluation showed the occlusion was opened with 
good flow, the drip was stopped. Integrillin was given 
followed with 24 hours integrillin drip. Neurological 
examination showed patient was alert, in good orien-
tation, mild dysarthria, partial facial weakness, both 
extremities moved equally, the NI�SS was 6 (mild 
stroke) and moved to CVC unit. 
In CVC unit patient was fully alert, BP was 
162/72 mm�g, �R 86 bpm, with mild neurological 
deficit. BP was stable under oral anti-hypertension, 
MAP target was 100. Neurological expertise showed 
minimal neurological deficit (mild stroke) and patient 
moved to adult ward on the next 3 days. Patient had 
discharged and controlled regularly to policlinic with 
NI�SS 0
Case Illustration 3
Mrs.EJ, 70 years old came to National Cardiovascular 
Center �arapan Kita Jakarta (NCC�K) to have elec-
tive coronary angiography due to stable angina pectoris 
CCS II. �e was also diagnosed as C�F Fc. II ec Old 
Inferior MCI. She presented chest pain with moderate 
activity and diminish with rest or sublingual nitrate, 
with duration about 5-10 minutes, the pain did not 
radiate and there were no diaphoretic, nausea nor 
vomiting. �e had been suffering these symptoms for 
last 2 months, with risk factors of hypertension and 
menopause. She had heart attack 4 months ago and 
hospitalized at Kuningan �ospital.
Physical examination revealed mild ill, blood pres-
sure was 140/70 mm�g, heart rate was 85 bpm, respi-
ratory rate 20 x/minutes, and body temperature was 
36,4o C. Auscultation revealed normal heart sound, 
normal vesicular sound with no rales and wheezing 
from lung examination, and other examinations was 
within normal limit.
The electrocardiogram showed sinus rhythm, QRS 
rate 75 bpm, QRS axis (-30), normal P wave, PR in-
terval 20 msec, QRS duration 4 msec, Q pathologic 
at II, III and aVF, T inverted at I, aVL, V3-V6. The 
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laboratory finding revealed hemoglobin was 11.2 g/dl, 
�ematokrit 34 vol%, WBC 7000/ul, ureum 14 mg/
dl and creatinin level was 0,9 mg/dl. 
Chest X-ray revealed cardiac enlargement with 
cardio-thoracic ratio 50%, aortic segment and pulmo-
nal segment were normal, flattening of cardiac waist, 
downward apex and no congestion nor infiltrate. 
Echocardiography showed EDD 54mm, ESD 41mm, 
with the ejection fraction 45%, global normokinetic, 
normal valves and diastolic dysfunction with abnormal 
relaxation. �is last medications were vaclo 1 x 75 mg, 
ISDN 3 x 10 mg, �yperil 1 x 5 mg, cardioaspirin 1 x 
100 mg, maintate 1 x 2.5 mg. 
The coronary angiography was performed upon 
this patient with the result, LM non significant stenosis 
at distal, LAD distal stenosis 80% after D2, stenosis 
70% at osteal D1 and stenosis 60-70% at osteal D2, 
distal goes to RCA. LCX was normal. RCA mid long-
stenosis 95% with severe calsification. 
After coronary angiography procedure carried 
out, the patient complaint of tiredness unable to open 
both eyes. The consciousness level was decreasing and 
started to snore. The National Institute of �ealth 
Stroke Scale (NI�SS) was 34 (severe stroke). MSCT 
brain was performed and showed ischemic stroke, 
no detection of intracranial hemorraghe. Then the 
patient was diagnosed as C�F Fc II CAD2 VD with 
the complication of CVD SN�. 
Patient was planned to perform cerebral percutane-
ous intra-arterial thrombolysis (PIAT) with r-TPA. JR 
Catheter was advanced to Right Internal Carotid Ar-
tery and cerebral angiography was carried out, showed 
stenosis with slow flow on Right Media Cerebral Ar-
tery (MCA) and no flow to Right Anterior Cerebral 
Artery. Then, the rTPA (actyles) was injected bolus 
3.5 mg through the Microcatheter which placed upon 
MCA, angiography evaluation showed the occlusion 
begin to be opened, followed with actyles drip 31.5 
mg within 60 minutes intra-catheter. Angiography 
evaluation showed stenosis was opened with good 
flow to Right Anterior Cerebral Artery. Neurological 
examination showed patient was somnolen, dysarthria, 
partial facial weakness, the strength of left extremities 
were decreased, the NI�SS was 20 (severe stroke) and 
moved to CVC unit. 
In CVC unit patient on the next day patient was 
fully alert, BP was 113/38 mm�g, �R 56 bpm, with 
mild neurological deficit. BP was stable under oral 
anti-hypertension, MAP target was 100. Neurological 
expertise showed minimal neurological deficit NI�SS 
6 (mild stroke) and patient moved to adult ward on 
the next 3 days. Patient had discharged and controlled 
regularly to policlinic with NI�SS 0.
Discussion
Ischemic stroke is a rare but well-known complication 
of cardiac or neurovascular catheter interventions at-
tributable mostly to embolism. Possible patho-mech-
anisms include direct arterial injury, air embolism, 
thrombus formation on the catheter or guide wire, and 
dislocation of pre-existing atherosclerotic plaques or 
thrombotic material, especially from the aortic arch.10 
Those 3 cases are the real example of how ischemic 
stroke possibly happen during procedure of coronary 
angiography. The similarities of 3 cases above are; above 
65 years old and post CABG except the case 3. The 
Figure 3. Case illustration 3: A. Before PIAT B. After PIAT C. Brain CT showed ischemic stroke
A B C
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complication happened while the operators were about 
to advance the catheter through the grafts. It gives us a 
very good lesson on how to be more careful and extra 
safe to perform any invasive procedure, and knowing 
exactly how to manage the complication immediately 
with correct standard procedure, so we do not put the 
patient in more harmful conditions.
Brain Imaging: Hemorraghe or Not Hemor-
raghe 
Brain imaging remains a required component of the 
emergency assessment of patients with suspected 
stroke. Both CT and MRI are options for imaging 
the brain, but for most cases and at most institutions, 
CT remains the most practical initial brain imaging 
test. A physician skilled in assessing CT or MRI stud-
ies should be available to examine the initial scan. In 
particular, the scan should be evaluated for evidence 
of early signs of infarction.11 Baseline CT findings, 
including the presence of ischemic changes involving 
more than one third of a hemisphere, have not been 
predictors of responses to treatment with rtPA when 
the agent is administered within the 3-hour treatment 
window. Information about multimodal CT and MRI 
of the brain suggests that these diagnostic studies may 
help in the diagnosis and treatment of patients with 
acute stroke.8
Imaging of the brain is recommended before 
initiating any specific therapy to treat acute ischemic 
stroke (Class I, Level of Evidence A).Nevertheless, 
data are insufficient to state that, with the exception 
of hemorrhage, any specific CT finding (including 
evidence of ischemia affecting more than one third of 
a cerebral hemisphere) should preclude treatment with 
rtPA within 3 hours of onset of stroke (Class IIb, Level 
of Evidence A). Emergency treatment of stroke should 
not be delayed in order to obtain multimodal imaging 
studies (Class III, Level of Evidence C).8
It is clear enough stated at the A�A guidelines 
for the early management of adults with ischemic 
stroke that brain imaging is mandatory before initiat-
ing any specific therapy, otherwise it will do harmful 
to the patient. Contrary to this statement on the case 
illustration 1, brain imaging was performed after the 
therapy instead due to limitation of time. Fortunately 
the patient was in good condition and was proof with 
no detection of intracranial hemorraghe afterward. 
According to the A�A guidelines, it could have been 
harmful to the patient.
Neurological Examination and Stroke Scale 
Scores
The evaluation and initial treatment of patients with 
stroke should be performed as a priority in the hos-
pital. The development of an organized protocol and 
stroke team should speed the clinical assessment, the 
performance of diagnostic studies, and decisions for 
early management. The clinical assessment (history, 
general examination, and neurological examination) 
remains the cornerstone of the evaluation. The goals 
are to determine whether the patient has had a stroke 
and to establish potential contraindications for emer-
gency treatment with agents such as rTPA. 8
A stroke rating scale, such as the National Institute 
of �ealth Stroke Scale (NI�SS) (table 1), provides 
important information about the severity of stroke. It 
provides prognostic information, and the score may 
influence decisions about acute treatment.   Some of the 
recommendations included in the present statement are 
influenced by the NI�SS. This scale can be performed 
with a reasonable degree of accuracy by practitioners in 
a broad range of specialties. Education in the nuances 
of NI�SS can improve the accuracy of this scale. Based 
on the NI�SS, all of case illustrations were presented as 
severe stroke with 30, 28 and 34 score respectively.
Because time is critical, a limited number of diagnos-
tic tests are recommended (table 2). These tests should 
be available on a 24-hours-per-day, 7-days-per-week 
basis. These tests are used to screen for ischemic stroke, 
to exclude important alternative diagnoses (especially 
intra-cerebral hemorrhage), to assess for serious co-
morbid diseases, and to search for acute medical or 
neurological complications of the stroke. Although it 
is desirable to know the results of these tests (table 2) 
before giving rtPA, thrombolytic therapy should not be 
delayed while awaiting the results unless there is clinical 
suspicion of a bleeding abnormality or thrombocytope-
nia, or the patient has received heparin or wafarin, or 
use of anticoagulants is not known.8 Regarding to these 
cases, all of the patients were received heparin due to 
catheter procedures, and by that time all the case illus-
trations, were only tested for blood glucose, ECG and 
oxygen saturation. The other tests were performed when 
patients had already transferred to the CVC unit.
Intra-arterial or intra-venous thrombolytic?
Based on SYNT�ESIS trial, the first randomized 
controlled trial comparing IAT and IVT with alteplase 
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in acute ischemic stroke, rapid initiation of IAT is a 
safe and feasible alternative to IVT in acute ischemic 
stroke.7 The PROACT II trial showed that intra-
arterial thrombolysis (IAT) is effective for treatment 
of acute ischaemic stroke attributable to M1 and M2 
segment occlusions. Incidence of symptomatic in-
tracranial haemorrhage (sIC�) was 10%.13 Based on 
Brekenfeld et.al study of 294 patients, showed that 
incidence of sIC� after IAT is distinctly low. This 
result underlines the important role of IAT in the 
treatment of acute stroke.14 
According to A�A guidelines for the early manage-
ment of adults with acute ischemic stroke, intravenous 
rtPA (0.9 mg/kg, maximum dose 90 mg) is recom-
mended for selected patients who may be treated 
within 3 hours of onset of ischemic stroke (Class I, 
Level of Evidence A). Intra-arterial thrombolysis is 
an option for treatment of selected patients who have 
major stroke of < 6 hours duration due to occlusions 
of the MCA and who are not otherwise candidates for 
intravenous rtPA (Class I, Level of Evidence B). Treat-
ment requires the patient to be at an experienced stroke 


Table 2. Immediate Diagnostic Studies : Evaluation of a 
Patient with Suspected Acute Ischemic Stroke8 
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≤14 mild stroke; 15-19 moderate stroke; ≥ 20 severe stroke12 
Table 1. National Institutes  of �ealth Stroke Scales8
≤14 mild stroke; 15-19 moderate stroke; ≥ 20 severe stroke12
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receive the drug. Fortunately, the drug could have been 
administered within less than 3 hours of the onset. 
According to A�A guideline about the characteristics 
of patients who could be treated with rTPA, those 3 
cases are eligible candidates for rtPA therapy, but the 
only pitfall was not assessing the brain CT on the first 
place for the case 1. The rest of criteria were fulfilled.
The monitoring and follow up at the cath-lab and 
CVC ward upon these cases before and after procedures, 
were correct, according to the A�A guidelines. But 
there was a controversial issue which was raised at the 
field about the need to obtain a follow up CT scan at 24 
hours after procedures before starting anticoagulants or 
antiplatelet agents. The neurologist thought no need for 
another CT scan 24 hours after procedure. To detect any 
changes could be done by clinical signs and symptoms, 
while in the other hand the cardiologist thought it was 
necessary to obtain clearly evidence or signs of hemor-
raghe. According to the A�A guideline, CT scan at 24 
hours after procedure is necessary to see any evidence of 
intracranial hemorraghe before starting anticoagulants or 
antiplatelet agents. Meanwhile in our cases, the antipltelet 
agents and anticoagulants were given to the patient after 
procedure before follow up CT scan. On the follow up at 
the ward and by phone after discharge, both patient case 
1 and 2 have a very good outcome regarding the ischemic 
stroke, no residual at all (NI�SS 0), unfortunately for 
the patient on the illustration case 3, whom medicated 
without IAT nor IVT he has residual neurological deficit, 
which impacts his quality of life.
Although it has been stated clearly on the A�A 
guidelines for early management of Adults with 
sacute ischemic stroke, up until now the procedure 
of IAT or IVT upon acute ischemic stroke is not 
established yet in standard operational procedure 
of National Cardiovascular Center �arapan Kita 
Jakarta, which perhaps makes the physicians hesitate 
on performing these procedures due to legal aspects, 
while in the other hand the risk of acute ischemic 
stroke remain the potential threats on every single 
coronary angiography or any intensive catheter 
based procedures.
Summary
Ischemic stroke is a rare but well-known complication 
of cardiac-catheter interventions attributable mostly 
to embolism. We presented 3 cases of acute ischemic 
stroke which happened during coronary angiography 
center with immediate access to cerebral angiography 
and qualified interventionalists. Facilities are encour-
aged to define criteria to credential individuals who can 
perform intra-arterial thrombolysis (Class I, Level of 
Evidence C). Intra-arterial thrombolysis is reasonable 
in patients who have contraindications to use of intra-
venous thrombolysis, such as recent surgery (Class IIa, 
Level of Evidence C). The availability of intra-arterial 
thrombolysis should generally not preclude the intra-
venous administration of rtPA in otherwise eligible 
patients (Class III, Level of Evidence C).8
Three trials that mentioned above, state that IAT is 
preferable. Meanwhile the A�A guideline suggests us 
to perform IVT at the first place unless in some other 
criteria which make IVT become out of option or the 
onset more than 3 hours. But on these cases, IAT is 
the better option due to very short time to-treatment 
and readily available resources. The potential problem 
that had happened during that time was the absence 
of rtPA itself, and had to wait for another 1-2 hours to 
Table 3. Characteristics of Patients With Ischemic Stroke  Who Could 
Be Treated With rtPA8


due to occlusions of the MCA and who are not otherwise candidates for intravenous rtPA (Class I, Level 
of Evidence B). Treatment requires the patient to be at an experienced stroke center with immediate 
access to cerebral angiography and qualified interventionalists. Facilities are encouraged to define criteria 
to credential individuals who can perform intra-arterial thrombolysis (Class I, Level of Evidence C). 
Intra-arterial thrombolysis is reasonable in patients who have contraindications to use of intravenous 
thrombolysis, such as recent surgery (Class IIa, Level of Evidence C). The availability of intra-arterial 
thrombolysis should generally not preclude the intravenous administration of rtPA in otherwise eligible 
patients (Class III, Level of Evidence C).8 
Three trials that mentioned above, state that IAT is preferable. Meanwhile the AHA guideline 
suggests us to perform IVT at the first place unless in some other criteria which make IVT become out of 
option or the onset more than 3 hours. But on these cases, IAT is the better option due to very short time 
to-treatment and readily available resources. The potential problem that had happened during that time 
was the absence of rtPA itself, and had to wait for another 1-2 hours to receive the drug. Fortunately, the 
drug could have been administered within less than 3 hours of the onset. According to AHA guideline 
about the characteristics of patients who could be treated with rTPA, those 3 cases are eligible candidates 
for rtPA therapy, but the only pitfall was not assessing the brain CT on the first place for the case 1. The 
rest of criteria were fulfilled. 
Table 3. Characteristics of Patients With Ischemic Stroke  Who Could Be Treated With 
rtPA8  
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procedures. All of them (NI�SS 30, 20 and 34) were 
treated immediately with intra-arterial thrombolysis 
rtPA. All of the cases had a very good outcome with 
no residual of stroke (NI�SS 0). Although it has 
been stated clearly in the A�A guidelines for the early 
management of adults with ischemic stroke, up until 
now the procedure of IAT or IVT upon acute ischemic 
stroke is not established yet in standard operational 
procedure of National Cardiovascular Center �arapan 
Kita (NCC�K) Jakarta, which perhaps makes the 
physicians hesitate on performing these procedures 
due to legal aspects, while in the other hand the risks 
of acute ischemic stroke remain the potential threats 
on every single coronary angiography or any intensive 
catheter based procedures.
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